Show simple item record

dc.contributor.authorRatnakumaran, R
dc.contributor.authorMohajer, J
dc.contributor.authorWithey, SJ
dc.contributor.authorH Brand, D
dc.contributor.authorLee, E
dc.contributor.authorLoblaw, A
dc.contributor.authorTolan, S
dc.contributor.authorvan As, N
dc.contributor.authorTree, AC
dc.contributor.authorPACE Trial Investigators,
dc.coverage.spatialIreland
dc.date.accessioned2024-04-30T15:57:07Z
dc.date.available2024-04-30T15:57:07Z
dc.date.issued2024-05-01
dc.identifier100769
dc.identifierS2405-6308(24)00046-6
dc.identifier.citationClinical and Translational Radiation Oncology, 2024, 46 pp. 100769 -
dc.identifier.issn2405-6308
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/6216
dc.identifier.eissn2405-6308
dc.identifier.eissn2405-6308
dc.identifier.doi10.1016/j.ctro.2024.100769
dc.identifier.doi10.1016/j.ctro.2024.100769
dc.description.abstractPURPOSE: The urethra is a critical structure in prostate radiotherapy planning; however, it is impossible to visualise on CT. We developed a surrogate urethra model (SUM) for CT-only planning workflow and tested its geometric and dosimetric performance against the MRI-delineated urethra (MDU). METHODS: The SUM was compared against 34 different MDUs (within the treatment PTV) in patients treated with 36.25Gy (PTV)/40Gy (CTV) in 5 fractions as part of the PACE-B trial. To assess the surrogate's geometric performance, the Dice similarity coefficient (DSC), Hausdorff distance (HD), mean distance to agreement (MDTA) and the percentage of MDU outside the surrogate (UOS) were calculated. To evaluate the dosimetric performance, a paired t-test was used to calculate the mean of differences between the MDU and SUM for the D99, D98, D50, D2 and D1. The D(n) is the dose (Gy) to n% of the urethra. RESULTS: The median results showed low agreement on DSC (0.32; IQR 0.21-0.41), but low distance to agreement, as would be expected for a small structure (HD 8.4mm (IQR 7.1-10.1mm), MDTA 2.4mm (IQR, 2.2mm-3.2mm)). The UOS was 30% (IQR, 18-54%), indicating nearly a third of the urethra lay outside of the surrogate. However, when comparing urethral dose between the MDU and SUM, the mean of differences for D99, D98 and D95 were 0.12Gy (p=0.57), 0.09Gy (p=0.61), and 0.11Gy (p=0.46) respectively. The mean of differences between the D50, D2 and D1 were 0.08Gy (p=0.04), 0.09Gy (p=0.02) and 0.1Gy (p=0.01) respectively, indicating good dosimetric agreement between MDU and SUM. CONCLUSION: While there were geometric differences between the MDU and SUM, there was no clinically significant difference between urethral dose-volume parameters. This surrogate model could be validated in a larger cohort and then used to estimate the urethral dose on CT planning scans in those without an MRI planning scan or urinary catheter.
dc.formatElectronic-eCollection
dc.format.extent100769 -
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofClinical and Translational Radiation Oncology
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectProstate radiotherapy
dc.subjectStereotactic body radiotherapy
dc.subjectSurrogate
dc.subjectUrethra
dc.titleDeveloping and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity.
dc.typeJournal Article
dcterms.dateAccepted2024-03-23
dc.date.updated2024-04-19T09:47:05Z
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1016/j.ctro.2024.100769
rioxxterms.licenseref.startdate2024-05-01
rioxxterms.typeJournal Article/Review
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/38586079
pubs.organisational-groupICR
pubs.organisational-groupICR/Primary Group
pubs.organisational-groupICR/Primary Group/ICR Divisions
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Stereotactic and Precision Body Radiotherapy
pubs.organisational-groupICR/Students
pubs.organisational-groupICR/Students/PhD and MPhil
pubs.organisational-groupICR/Students/PhD and MPhil/17/18 Starting Cohort
pubs.organisational-groupICR/Students/PhD and MPhil/22/23 Starting Cohort
pubs.publication-statusPublished online
pubs.publisher-urlhttp://dx.doi.org/10.1016/j.ctro.2024.100769
pubs.volume46
dc.contributor.icrauthorRatnakumaran, Ragu
icr.provenanceDeposited by Dr Ragu Ratnakumaran on 2024-04-19. Deposit type is initial. No. of files: 1. Files: Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxici.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/